Download PDF
Zeitschrift für Orthomolekulare Medizin 2018; 16(04): 12-19
DOI: 10.1055/a-0761-1902
Wissen
© Georg Thieme Verlag KG Stuttgart · New York

Omega-3-Fettsäuren im Sport – Mängel erkennen und beheben

Clemens von Schacky
Further Information

Publication History

Publication Date:
04 February 2019 (online)

    Permissions and Reprints

Zusammenfassung

Bei Athleten, die ihren Körper in besonders starker Weise beanspruchen, erkennt man die vielfältigen Bedeutungen eines hohen ω-3-Indexes ebenso wie Leistungssportler in besonderer Weise von der Höhe ihres ω-3-Index abhängig sind. EPA und DHA, nicht die pflanzliche α-Linolensäure, sind geeignet, den ω-3-Index zu erhöhen. Ein ω-3-Index im Zielbereich von 8–11 % bedeutet Minimierung von Muskelkater und -abbau, eine Optimierung bestimmter kardiopulmonaler Parameter, eine Minimierung des Risikos für den plötzlichen Herztod, eine Optimierung komplexer kognitiver Leistungen wie Reaktionszeit oder Aufmerksamkeitsspanne, möglicherweise eine Minimierung der Konsequenzen von Hirntraumata, eine Optimierung der psychiatrischen/psychischen Situation und weitere positive Aspekte. Deshalb gehört die Bestimmung des HS-Omega-3-Index in die Laborroutine der Sportlerbetreuung. In den meisten Fällen wird ein ω-3-Index unterhalb des Zielbereiches von 8–11 % erkannt werden, was dann eine Supplementation mit entsprechenden Nahrungsergänzungsmitteln erfordert.

Schlüsselwörter

Omega-3-Fettsäuren - Muskel - Sport - Leistungssport - EPA - DHA - ω-3-Index - HS-Omega-3-Index - Supplementation
 

  • Literatur

  • 1 Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007; 32: 619-34
    CrossrefPubMedSearch in Google Scholar
  • 2 Kleber ME, Delgado GE, Lorkowski S, März W, von Schacky C. Omega-3 fatty acids and mortality in patients referred for coronary angiography – The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2016; 252: 157-81
    Search in Google Scholar
  • 3 Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Flöel A. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014; 24: 3059-68
    CrossrefPubMedSearch in Google Scholar
  • 4 Schuchardt JP, Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013; 89: 1-8
    CrossrefPubMedSearch in Google Scholar
  • 5 Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova®) compared to Lovaza® in a pharmacokinetic single-dose evaluation study. J Clin Lipidol 2012; 6: 573-84
    CrossrefPubMedSearch in Google Scholar
  • 6 Köhler A, Bittner D, Löw A, von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 2010; 104: 729
    CrossrefPubMedSearch in Google Scholar
  • 7 Köhler A, Heinrich J, von Schacky C. Bioavailability of dietary omega-3 fatty acids in a variety of sausages in healthy individuals. Nutrients 2017; 9: 629
    CrossrefPubMedSearch in Google Scholar
  • 8 Hussey EK, Portelli S, Fossler MJ. et al. Relative bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat dosing in healthy volunteers. Clin Pharm Drug Develop 2012; 1: 14-23
    Search in Google Scholar
  • 9 Qin Y, Nyheim H, Haram EM, Moritz JM, Hustvedt SO. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate. Lipids Health Dis 2017; 16: 204
    CrossrefPubMedSearch in Google Scholar
  • 10 Lane KE, Derbyshire EJ. Omega-3 fatty acids – A review of existing and innovative delivery methods. Crit Rev Food Sci Nutr 2018; 58: 62-69
    CrossrefPubMedSearch in Google Scholar
  • 11 Voruganti VS, Higgins PB, Ebbesson SOE. et al. Variants in CPT1A, FADS1, and FADS2 are associated with higher levels of estimated plasma and erythrocyte delta-5 desaturases in Alaskan Eskimos. Front Genet 2012; 3: 86
    PubMedSearch in Google Scholar
  • 12 Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJ. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis 2012; 225: 425-31
    CrossrefPubMedSearch in Google Scholar
  • 13 Harris WS, and von Schacky C. The Omega-3 Index: A New Risk Factor for Death from CHD? Preventive Medicine. 2004; 39: 212-20
    PubMedSearch in Google Scholar
  • 14 von Schacky C. Der HS-Omega 3 Index®: klinische Wertigkeit standardisierter Fettsäureanalytik. J Lab Med 2014; 38: 167-78
    Search in Google Scholar
  • 15 von Schacky C. The Omega-3 Index as a Risk Factor for Cardiovascular Diseases. Prostaglandins and Other Lipid Mediators 2011; 96: 94-8
    CrossrefPubMedSearch in Google Scholar
  • 16 Heydari B, Abdullah S, Pottala JV. , et al. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation 2016; 134: 378-91
    CrossrefPubMedSearch in Google Scholar
  • 17 Scorletti E, Bhatia L, McCormick KG. et al. WELCOME Study. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology 2014; 60: 1211-21
    CrossrefPubMedSearch in Google Scholar
  • 18 von Schacky C. Omega-3 Index for Cardiovascular Health. Nutrients 2014; 6: 799-814
    CrossrefPubMedSearch in Google Scholar
  • 19 Hammond T, Gialloreto C, Kubas H, Hap Davis H. 4th. The prevalence of failure-based depression among elite athletes. Clin J Sport Med 2013; 23: 273-7
    CrossrefPubMedSearch in Google Scholar
  • 20 von Schacky C, Kemper M, Haslbauer R, Halle M. Low Omega-3 Index in 106 german elite winter endurance athletes: a pilot study. Int J Sport Nutr Exerc Metab 2014; 24: 559-64
    CrossrefPubMedSearch in Google Scholar
  • 21 Wilson PB, Madrigal LA. Associations Between Whole Blood and Dietary Omega-3 Polyunsaturated Fatty Acid Levels in Collegiate Athletes. Int J Sport Nutr Exerc Metab 2016; 26: 497-505
    CrossrefPubMedSearch in Google Scholar
  • 22 von Schacky C. Omega-3 Fettsäuren im Sport. Vitalstoffe 2015; 5/4: 10-16
    Search in Google Scholar
  • 23 Kim J, Lee J. A review of nutritional intervention on delayed onset muscle soreness. Part I J Exerc Rehabil 2014; 10: 349-56
    PubMedSearch in Google Scholar
  • 24 Lembke P, Capodice J, Hebert K, Swenson T. Influence of omega-3 (n3) index on performance and wellbeing in young adults after heavy eccentric exercise. J Sports Sci Med 2014; 13: 151-6
    PubMedSearch in Google Scholar
  • 25 Mickleborough TD, Sinex JA, Platt D, Chapman RF, Hirt M. The effects PCSO-524®, a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial. J Int Soc Sports Nutr 2015; 12: 10
    CrossrefPubMedSearch in Google Scholar
  • 26 Philpott JD, Donnelly C, Walshe IH. et al. Adding Fish Oil to Whey Protein, Leucine, and Carbohydrate Over a Six-Week Supplementation Period Attenuates Muscle Soreness Following Eccentric Exercise in Competitive Soccer Players. Int J Sport Nutr Exerc Metab 2018; 28: 26-36
    CrossrefPubMedSearch in Google Scholar
  • 27 Smith GI, Atherton P, Reeds DN. et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 2011; 93: 402-12
    CrossrefPubMedSearch in Google Scholar
  • 28 Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr 2015; 102: 115-22
    CrossrefPubMedSearch in Google Scholar
  • 29 Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N. Jr. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 2016; 63: 132-52
    CrossrefPubMedSearch in Google Scholar
  • 30 Bloomer RJ, Larson DE, Fisher-Wellman KH, Galpin AJ, Schilling BK. Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study. Lipids Health Dis 2009; 8: 36
    CrossrefPubMedSearch in Google Scholar
  • 31 Tartibian B, Maleki BH, Abbasi A. Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men. Clin J Sport Med 2011; 21: 131-7
    CrossrefPubMedSearch in Google Scholar
  • 32 Walser B, Stebbins CL. Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise. Eur J Appl Physiol 2008; 104: 455-61
    CrossrefPubMedSearch in Google Scholar
  • 33 Peoples GE, McLennan PL, Howe PR, Groeller H. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008; 52: 540-7
    CrossrefPubMedSearch in Google Scholar
  • 34 Buckley JD, Burgess S, Murphy KJ, Howe PR. DHA-rich fish oil lowers heart rate during submaximal exercise in elite Australian Rules footballers. J Sci Med Sport 2009; 12: 503-7
    CrossrefPubMedSearch in Google Scholar
  • 35 Macartney MJ, Hingley L, Brown MA, Peoples GE, McLennan PL. Intrinsic heart rate recovery after dynamic exercise is improved with an increased omega-3 index in healthy males. Br J Nutr 2014; 112: 1984-92
    CrossrefPubMedSearch in Google Scholar
  • 36 Moyers B, Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Relation of Whole Blood n-3 Fatty Acid Levels to Exercise Parameters in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study). Am J Cardiol 2011; 107: 1149-54
    CrossrefPubMedSearch in Google Scholar
  • 37 AbuMweis S, Jew S, Tayyem R, Agraib L. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. J Human Nutr Diet 2018; 31: 67-81
    CrossrefPubMedSearch in Google Scholar
  • 38 Zebrowska A, Mizia-Stec K, Mizia M, Gąsior Z, Poprzęcki S. Omega-3 fatty acids supplementation improves endothelial function and maximal oxygen uptake in endurance-trained athletes. Eur J Sport Sci 2014 Sep 1: 1-10
    Search in Google Scholar
  • 39 Brilla LR, Landerholm TE. Effect of fish oil supplementation and exercise on serum lipids and aerobic fitness. J Sports Med Phys Fitness 1990; 30: 173-80
    PubMedSearch in Google Scholar
  • 40 Raastad T, Høstmark AT, Strømme SB. Omega-3 fatty acid supplementation does not improve maximal aerobic power, anaerobic threshold and running performance in well-trained soccer players. Scand J Med Sci Sports 1997; 7: 25-31
    PubMedSearch in Google Scholar
  • 41 https://www.wada-ama.org/sites/default/files/resources/files/2018_prohibited_list_german.pdf , aufgerufen am 12. 09.18
  • 42 Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 2011; 123: 1594-1600 . Clin J Sport Med 2013; 23: 273 – 7
    CrossrefPubMedSearch in Google Scholar
  • 43 Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013; 61: 1027-40
    CrossrefPubMedSearch in Google Scholar
  • 44 Siscovick DS, Raghunathan TE, King I. et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the riskof primary cardiac arrest. J Am Med Assoc 1995; 275: 836-7
    Search in Google Scholar
  • 45 Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-8
    CrossrefPubMedSearch in Google Scholar
  • 46 Marchioli R, Barzi F. Bomba et al. GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-903
    CrossrefPubMedSearch in Google Scholar
  • 47 Weiler JM, Brannan JD, Randolph CC. et al. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol 2016; 138: 1292-1295
    CrossrefPubMedSearch in Google Scholar
  • 48 Williams NC, Hunter KA, Shaw DE. et al. Comparable reductions in hyperpnoea-induced bronchoconstriction and markers of airway inflammation after supplementation with 6·2 and 3·1 g / d of long-chain n-3 PUFA in adults with asthma. Br J Nutr 2017; 117: 1379-89
    CrossrefPubMedSearch in Google Scholar
  • 49 Hart J Jr, Kraut MA, Womack KB, Strain J, Didehbani N, Bartz E, Conover H, Mansinghani S, Lu H, Cullum CM. Neuroimaging of cognitive dysfunction and depression in aging retired National Football League players: a cross-sectional study. JAMA Neurol 2013; 70: 326-35
    CrossrefPubMedSearch in Google Scholar
  • 50 Rubin TG, Catenaccio E, Fleysher R. et al. MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men. Radiology 2018; 289 (2): 478-86
    CrossrefPubMedSearch in Google Scholar
  • 51 Patricios JS, Ardern CL, Hislop MD. et al. Implementation of the 2017 Berlin Concussion in Sport Group Consensus Statement in contact and collision sports: a joint position statement from 11 national and international sports organisations. Br J Sports Med 2018; 52: 635-641
    CrossrefPubMedSearch in Google Scholar
  • 52 Oliver JM, Jones MT, Kirk KM. et al. Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football. Med Sci Sports Exerc 2016; 48: 974-82
    PubMedSearch in Google Scholar
  • 53 Pu H, Jiang X, Wei Z. et al. Repetitive and Prolonged Omega-3 Fatty Acid Treatment After Traumatic Brain Injury Enhances Long-Term Tissue Restoration and Cognitive Recovery. Cell Transplant 2017; 26: 555-69
    CrossrefPubMedSearch in Google Scholar
  • 54 Noguchi H, Nishi D, Matsumura K, Hamazaki K, Hamazaki T, Matsuoka YJ. Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: A randomized, placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids 2017; 127: 1-5
    CrossrefPubMedSearch in Google Scholar
  • 55 Guzmán JF, Esteve H, Pablos C, Pablos A, Blasco C, Villegas JA. DHA-Rich Fish Oil Improves Complex Reaction Time in Female Elite Soccer Players. J Sports Sci Med 2011; 10: 301-5
    PubMedSearch in Google Scholar
  • 56 von Schacky C. ω-3 Fettsäuren und Hirnfunktion. Zs f Orthomol Med 2016; 2: 6-10
    Thieme ConnectSearch in Google Scholar
  • 57 Grosso G, Pajak A, Marventano S. et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014; 9: e96905
    CrossrefPubMedSearch in Google Scholar
  • 58 Hibbeln JR, Gow RV. The potential for military diets to reduce depression, suicide, and impulsive aggression: a review of current evidence for omega-3 and omega-6 fatty acids. Mil Med 2014; 179 (11 Suppl): 117-28
    CrossrefPubMedSearch in Google Scholar
  • 59 von Schacky C. Omega-3 Fettsäuren und Major Depression. Vitalstoffe 2017; 3: 28-33
    Search in Google Scholar
  • 60 Ravindran AV, Balneaves LG, Faulkner G. et al. CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Can J Psychiatry 2016; 61: 576-87
    CrossrefPubMedSearch in Google Scholar
  • 61 McNamara RK, Welge JA. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. Bipolar Disord 2016; 18: 300-6
    CrossrefPubMedSearch in Google Scholar
  • 62 Saunders EF, Ramsden CE, Sherazy MS, Gelenberg AJ, Davis JM, Rapoport SI. Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies. J Clin Psychiatry 2016; 77: e1301-e1308
    CrossrefPubMedSearch in Google Scholar
  • 63 Naguy A. Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based? J Diet Suppl 2018; 15: 124-8
    CrossrefPubMedSearch in Google Scholar
  • 64 Messamore E, Almeida DM, Jandacek RJ, McNamara RK. Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application. Prog Lipid Res 2017; 66: 1-13
    CrossrefPubMedSearch in Google Scholar
  • 65 Messamore E, McNamara RK. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation. Lipids Health Dis 2016; 15: 25
    CrossrefPubMedSearch in Google Scholar
  • 66 EFSA Journal. Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). 2012; 10 (07) : 2815
    PubMed
  • 67 Yokoyama M, Origasa H, Matsuzaki M. et al. Japan EPA lipid intervention study (JELIS) Investigators. Japan EPA intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369: 1090-8
    CrossrefPubMedSearch in Google Scholar